IDEXX to wind down Russian subsidiary, end direct operations

IDEXX LABORATORIES INC /DE

Revenue from Russia represented less than 1% of total 2021 consolidated revenue.
No manufacturing or significant supply arrangements in Russia.
Wind-down includes liquidation of the sole Russian subsidiary and direct operations.
Company providing transition support to impacted Russian employees.
Limited products for human or animal health will continue via third-party distributors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.